Phase I Comparative Bioavailability Study
NCT00777582
·
clinicaltrials.gov ↗
PHASE1
Phase
ACTIVE_NOT_RECRUITING
Status
197
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumors
Interventions
DRUG:
AZD2281
Sponsor
AstraZeneca